InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,425.20
(
0.54%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.39
(
-0.23%
)
Bitcoin
64,244.28
(
-0.04%
)
Post# of 659175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

matt24d

Send PM Follow Ignore
Followers 396
Posts 86395
Boards Moderated 2
Alias Born 02/05/2004

matt24d

Re: None

Thursday, 10/10/2019 10:47:05 AM

Thursday, October 10, 2019 10:47:05 AM

Post# of 659175
AKBA just flipped the SAR. Been buying this up the last few weeks. I think their current drugs sales have been showing nice growth and their new drug Vadadustat could be a block buster. Also they reported positive top-line results from a pivotal Phase 3 comparative study evaluating Riona® Tablets 250mg (generic name in Japan: ferric citrate hydrate) for the treatment of iron deficiency anemia (IDA) in adult patients in Japan. SO there is a good chance their drug gets approval in Japan early next year.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up